SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-215038
Filing Date
2023-08-17
Accepted
2023-08-17 16:06:01
Documents
12
Period of Report
2023-08-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d523220d8k.htm   iXBRL 8-K 22635
  Complete submission text file 0001193125-23-215038.txt   146678

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atnx-20230811.xsd EX-101.SCH 2851
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE atnx-20230811_lab.xml EX-101.LAB 18706
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atnx-20230811_pre.xml EX-101.PRE 11696
6 EXTRACTED XBRL INSTANCE DOCUMENT d523220d8k_htm.xml XML 3528
Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 716-898-8625
Athenex, Inc. (Filer) CIK: 0001300699 (see all company filings)

IRS No.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38112 | Film No.: 231181903
SIC: 2834 Pharmaceutical Preparations